Submitted by Anonymous (not verified) on 25 August 2026 - 15:25
Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin, Date of authorisation: 30/11/2009, Revision: 20, Status: Authorised
Source:
